Earnings Call · Q1 FY2024·2024-05-07

Q1 24EPS +12.50%·Rev n/aQ4 23EPS -33.33%·Rev n/aQ3 23EPS +23.08%·Rev n/aQ2 23EPS +8.33%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Carl Hansen — President

Andrew Booth — Chief Financial Officer

−1.7%1d on move date−1.8% vs SPY3d−3.9%5d−6.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access